Commercial returns in emerging health markets require more than innovative products—they demand robust distribution networks, patient engagement platforms, and strategic financing. The convergence of demographic shifts, rising affluence, increased healthcare spending, technological innovation, and generative AI are creating unprecedented investment opportunities across Asia. Markets like Indonesia, India, and emerging East African economies—with their rapidly growing middle classes, tech-savvy young populations, and strong policy support—offer significant potential for private sector investment.
At the J.P. Morgan Healthcare Conference 2026 in San Francisco, the Alliance convened another strategic panel on January 14, From Products to Patients: Capturing Value in Asia’s Growth Markets, bringing together Gilead Sciences’ SVP of Emerging Markets, the head of U.S. DFC’s global health investments, and the CEOs of reach52 and Nivi, Inc. to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia.
Read the insights report and listen to the audio recording here.
Learn more about the Alliance’s financing and investing work, and find insights from our JPM 2024 and 2025 panels here.
PANELISTS
Edward Booty, CEO, reach52
Edward is the founder and CEO of reach52; a fast-growing healthcare startup on a mission to connect the 52% of the world that lack access to health services. reach52 focusses on emerging markets product registration with sales and distribution management (reach52 Access); coupled with building demand and brands through integrated market development (reach52 Impact: training health workers, collecting data to build localised strategy; with health education and screening campaigns). Ed has launched reach52 operations across 15 markets in Asia and more recently Africa, building an ecosystem of 30 partners and expanding access to their products and services, (with in-market operations and digital platforms to enable this). He has worked in health systems across three continents; and has extensive experience in digital health, access to medicine and essential health products, health equity/public health campaigns, supply chain, government relations and public affairs, strategy, business development and product licensing and startup operations. Prior to reach52, Ed worked in healthcare consulting, for the UK National Health Service (NHS) and for a multinational pharmaceutical company in India, looking at access to medicine in non-urban areas. He is a graduate from the London School of Economics (LSE).
Janet Dorling, Senior Vice President, Intercontinental Region and Gilead Patient Solutions, Gilead Sciences
Janet Dorling is a dynamic leader with more than 25 years of experience in science and business. Currently she leads the ICR Region and GPS driving operational accountability across a large set of geographically and culturally diverse markets. Previously, she built and led the Global Commercial Strategy and Operations Team at Gilead. Prior to joining Gilead, Janet held successive C-suite positions at biotech start-ups, building commercial organizations from the ground up. From 2003 to 2017, she held Global and U.S. commercial roles at Roche and Genentech. Janet holds an MBA and a BS in MCB Genetics from U.C. Berkeley and an MS in Pharmacology and Cancer Biology from Duke University.
Siddhartha Goyal, CEO and Co-founder, Nivi, Inc.
Siddhartha is CEO and co-founder of Nivi, an AI powered conversational platform built for global health markets. He has raised over $6.4M for Nivi, has signed a global MSA with Merck to drive engagement on health journeys for its therapeutics, and expanded the business to 5 countries – India, Indonesia, Thailand, Kenya, and Nigeria. Nivi’s platform has engaged over 2 million users in women’s health journeys across its operating geographies. Prior to Nivi, Siddhartha served as an Entrepreneur in Residence at Invested Development, a fund focused on East Africa and India, where he worked with existing portfolio investments and sourced new investments. He also served as CTO of TinyURL, the world’s first link shortener serving over one billion redirects a month, and CTO of Assured Labor, a job marketplace acquired by OCCMundial in Mexico. Siddhartha holds Bachelor’s and Master’s degrees in Computer Science from the Massachusetts Institute of Technology. In his spare time he travels, is an avid outdoors enthusiast, and through various speaking engagements, provides insights into entrepreneurship for new and aspiring entrepreneurs.
Nafisa Jiwani, Associate Vice President, Health Initiatives, U.S. International Development Finance Corporation (DFC)
Nafisa Jiwani is a seasoned global health leader with deep experience in development finance, health systems, and strategy. She has extensive expertise in translating complex development policies and regulatory frameworks into actionable, high-impact financial transactions such as vaccine manufacturing projects, regional productions hubs, and critical supply chain infrastructure-aligned with global health security and pandemic preparedness strategies. She is skilled in working with governments, development finance institutions, multilaterals and private sector partners to design blended finance solutions and public-private partnerships that accelerate access to health technologies while fostering local production capacity and long-term sustainability. Currently, Nafisa is the Associate Vice President and Head of Global Health initiatives at the U.S. International Development Finance Corporation, where she leads innovative health transactions and capital mobilization initiatives in emerging markets. Previously, Nafisa held senior leadership roles at the U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention, advancing national priorities in value-based care, health innovation and public-private partnerships. Nafisa is passionate about creating scalable solutions that drive sustainability and resilience Worldwide. Ms. Jiwani’s career spans clinical and translational research, youth development, global health and development finance. She holds a Bachelor of Arts in Psychology from Southern Methodist University and a Master of Public Health in Management and Policy from Emory University’s Rollins Schools of Public Health.
Natasha Sunderji, Managing Director, Accenture [MODERATOR]
Natasha Sunderji is the Global Health and Nutrition Lead for Accenture’s social impact practice – Accenture Development Partnerships. She also co-leads Accenture’s Health Equity Center of Excellence. By engaging Accenture’s global workforce of over 750,000 employees, she works to address the world’s social, economic and environmental issues. Natasha is a visionary healthcare leader with over 20 years of experience advising multinational companies, nonprofits, foundations, and multilateral agencies on growth strategy, innovative business models, digital health, and cross sector partnerships. She is a vocal advocate for vulnerable and underserved communities. Natasha strives to drive care delivery transformation for health care organizations through financially sustainable, consumer centric, and data driven business models. She has worked with leading digital health platforms to design patient centric solutions, supported over 30 inclusive business models across low and middle-income countries, and advised policy makers on the regulations and investments needed to create robust digital health ecosystems. She was named a Top 50 Women Leader in San Francisco in 2023, and a Top 50 Innovator in 2020 by the World Summit AI community. Natasha holds a Bachelors in Biomedical Engineering from University of Toronto, and a Master’s in Public Policy from Harvard Kennedy School.